Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 8 October 2025

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Stock Performance: The 2025 Rollercoaster Ride Xenetic’s stock was relatively quiet for most of 2025 until early October, when it suddenly erupted. By Oct 8, 2025, XBIO had skyrocketed to levels not seen in years. On that day alone, the stock soared 123% to $9.58 (from a prior $4.29 close)finanzen.ch, after touching intraday highs well above $10. This move extended a remarkable run from under $3.50 at the start of the week to nearly $12-13 intraday on Oct 8ainvest.com. In fact, at one point XBIO was up about +195% in a single session according to real-time trackerstimothysykes.com. Such gains are extraordinary – even by penny stock standards
8 October 2025
·
Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Above Food Ingredients Inc. is a Canadian plant-based food tech company that went public via SPAC merger in 2024 Stocktwits. In 2025, its stock ABVE has been on a wild ride – climbing from penny-stock levels to over $4, an almost 8-fold increase in under a year Marketbeat. This meteoric rise comes as Above Food pivots beyond organic grains into gold-backed cryptocurrencies and next-gen financial tech, capturing investor imagination. Below, we dive into Above Food’s mission, business model, financials, stock performance, forecasts, expert commentary, strategic moves, ESG profile, and the latest news driving this micro-cap’s buzz. Company Background and Mission Founded in Regina, Saskatchewan, in 2023, Above Food began with a
8 October 2025
··
Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Company Overview: Operations & Business Model Cipher Mining Inc. is a pure-play Bitcoin miner operating industrial-scale data centers with a focus on ultra-low-cost powerts2.tech. The company strategically locates its facilities in regions with cheap, renewable-rich electricity (e.g. West Texas), often building behind-the-meter or adjacent to wind and solar farmsts2.techts2.tech. Its flagship “Black Pearl” site near Odessa, TX is a 150 MW facility designed for both Bitcoin mining and high-performance computing (HPC) workloadsts2.tech. As of mid-2025, Cipher’s deployed hashrate reached about 16.8 EH/s (exahashes per second), using next-gen ASIC machines for high energy efficiencyts2.tech. The company had aggressively expanded capacity – a 2.6 GW development pipeline of power projects positions Cipher for further growthts2.tech.
8 October 2025
··
Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Therapy (Target) Indication Status (2025) Current Ownership TECELRA(afamitresgene, targets MAGE-A4) Synovial sarcoma (unresectable/metastatic) FDA approved Aug 2024 Biospace; ~16 patients treated in launch year Nasdaq. Sold to US WorldMeds (2025) Adaptimmune Letetresgene (lete-cel, NY-ESO-1) MRCLS and synovial sarcoma (advanced solid tumors) Phase II completed (42% response rate) Stocktitan; FDA Breakthroughdesignation in 2025 Stocktitan; BLA filing planned for 2025. Sold to US WorldMeds (2025) Adaptimmune Uzatresegene (uza-cel, next-gen TCR) Solid tumors (MAGE-A4 TCR, partnered with Galapagos) Preclinical/IND-enabling stage; partnership deal $665M signed 2024 Fiercebiotech. Sold to US WorldMeds (2025) Adaptimmune PRAME-targeted TCR Multiple cancers (PRAME antigen) Preclinical (IND-enabling on hold to cut costs) Biospace. Retained by Adaptimmune Adaptimmune CD70-targeted TCR Hematologic malignancies
8 October 2025
·
Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Below, we dive deeper into each of these areas – from Snowflake’s business model and financials to the latest news, analyst insights, competitive dynamics, and what to expect going forward. Company Overview and Business Model Snowflake Inc. is a cloud data platform provider, offering data warehousing as a service alongside a suite of data analytics and sharing capabilities. Unlike traditional databases tied to a single cloud or on-premises, Snowflake’s platform is cloud-agnostic – it runs across Amazon AWS, Microsoft Azure, and Google Cloud, allowing customers to unify their data in one system regardless of cloud providermarkets.chroniclejournal.com. This flexibility has been a major selling point
8 October 2025
··
CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

Sources: Official company reports and press releases; Yahoo Finance and Zacks Investment Research; Reuters and CNBC interviews; TS2 Tech stock analysis and cybersecurity newsts2.technasdaq.commarkets.financialcontent.commarketbeat.comts2.techsiliconangle.comts2.tech. These provide the latest financial data, expert commentary, and industry context as of October 8, 2025.
8 October 2025
··
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Detailed Report 1. Stock Performance and Valuation Moderna’s stock was a market darling during the pandemic but has suffered a long decline. On Oct 7 2025 (the last trading day before the U.S. Columbus Day holiday), the stock closed at $27.34, down roughly 0.7% from $27.54 on the prior sessionstockinvest.us. Technical analysts at Stockinvest.us noted the shares were near the upper part of a wide falling trend and predicted a possible trading range of $26.40–$28.73 on Oct 8, with longer‑term support around $26 and resistance near $31stockinvest.us. While short‑term signals were positive, they cautioned that the overall downward trend remainsstockinvest.us. Because multiple financial
8 October 2025
··
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia at a Glance: CRISPR Trailblazer in 2025 Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a clinical-stage biotechnology company at the forefront of CRISPRgene editing medicines. Headquartered in Cambridge, MA, Intellia was one of the first companies to harness CRISPR-Cas9 technology to develop potential in vivo therapies – treatments delivered directly into the body to edit genes inside patients’ cells. In fact, Intellia reported the first-ever clinical evidence that CRISPR could provide a therapeutic benefit in humans via in-body gene editing, showing in 2021 that a one-time IV infusion could drastically lower a disease-causing protein in patients ts2.tech. This pioneering achievement, accomplished with their transthyretin amyloidosis (ATTR)
8 October 2025
··
TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

Overview: TSMC’s Business and Recent Performance Taiwan Semiconductor Manufacturing Co. (TSMC) is the world’s largest contract chipmaker (pure-play foundry), producing advanced semiconductors for clients like Apple, NVIDIA, AMD, and many otherstaiwannews.com.twts2.tech. Rather than selling its own branded chips, TSMC builds chips to order, focusing on cutting-edge manufacturing processes. This model has made TSMC a pillar of global tech supply chains and given it an estimated 60%+ market share of the overall foundry market (and over 90% share in the most advanced nodes)ts2.tech. Financially, TSMC has been on a strong growth trajectory. In Q2 2025, TSMC’s revenue reached US$30.1 billion, a 44%year-on-year surge, with net profit of T$398.3 billion, driven by
8 October 2025
··
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Overview: Apple Inc. and Recent Performance Apple Inc. – the world’s largest company by market capitalization – has had a mixed 2025 so far. With a market cap around $3.8 trillionts2.tech, Apple’s size means even modest growth is hard-fought. Year-to-date, AAPL stock is roughly flat (+~2%), underperforming the broader tech sectorts2.tech. This muted performance comes despite Apple achieving record financial results in 2025 (its June quarter revenue jumped ~10% YoY to $94 billion)ts2.tech. Early in the year the stock sold off amid market rotation and AI hype elsewhere, at one point down ~17%. But a strong rebound in late summer – fueled by booming iPhone sales –
8 October 2025
··
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco’s Business Model & Market Position Cisco Systems is best known as the world’s largest vendor of networking hardware and software, powering much of the internet’s infrastructure. The company’s business model centers on selling network equipment (like routers, switches, and wireless access points), along with security solutions, collaboration tools (e.g. Webex conferencing gear/software), and observability software (monitoring and analytics, bolstered by its 2024 acquisition of Splunk). In addition, Cisco provides a range of services – from technical support and maintenance contracts to cloud-managed software subscriptions. Cisco generates revenue both through direct sales and via a global channel of resellers and distributors, ensuring its products reach enterprises of all sizes and governments worldwidenasdaq.com. This
8 October 2025
·
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

Current Stock Price and Performance (Oct 8 2025) UnitedHealth Group’s share price has been volatile in 2025. On 8 Oct 2025 the stock closed around $372—IndMoney quoted $372.93 while Investing.com listed $372.64indmoney.cominvesting.com. Reuters reported that the last trade was $371.46, up 2.15 % from the previous dayreuters.com. The wide 52‑week range ($234.60‑$630.73) highlights the enormous drawdown from April’s peak and underscores the severity of the 2025 sell‑off. The stock’s average daily trading volume is about 5.9 million shares, and its beta of 0.47 indicates less volatility than the S&P 500reuters.commarketbeat.com. Year‑to‑date performance remains negative (‑28 % to ‑37 % depending on the reference period), but shares have rebounded more
8 October 2025
Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

Sources: Palo Alto Networks and CyberArk deal coverage – Reutersreuters.comreuters.com; Q4 2025 earnings and guidance – Reutersreuters.com, Futurumfuturumgroup.comfuturumgroup.com; Analyst ratings and price targets – StockAnalysisstockanalysis.comstockanalysis.com; Competitive landscape – Bullish Bearsbullishbears.combullishbears.com; Unit 42 threat intel news – ts2.techts2.tech; Expert quotes – Reutersreuters.com, Breakingviewsreuters.com; Stock performance data – Yahoo/Benzingahotcandlestick.com.
8 October 2025
··
Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Unraveling Confluent (CFLT) Stock: Latest Price, AI‑Driven Buzz & What Experts Say

Current Stock Price & Recent Performance (as of 8 Oct 2025) Date Open High Low Close Daily Change Notes 8 Oct 2025 $23.72 $24.07 $21.98 $22.84 −10.18 % Stock decline amid deal speculation and market volatilitystockanalysis.com. 7 Oct 2025 $21.33 $21.33 $20.12 $20.73 −2.50 % Day after Reuters’ sale‑rumor report; shares closed near weekly lowstockanalysis.com. 6 Oct 2025 $20.50 $21.49 $20.23 $21.26 +7.36 % Stock rallied following takeover rumorsinvestors.confluent.io. Confluent’s closing price on 8 Oct 2025 was around $22.84stockanalysis.com. INDmoney’s summary for the week lists a closing price of $20.74 and a day’s high of $21.33indmoney.com; the difference likely reflects after‑hours moves or data update timing. The stock trades well below its 52‑week
8 October 2025
·
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025

AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025

Introduction: A New Kind of Biotech Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is redefining drug discovery by combining cutting-edge biology and data science. Based in Salt Lake City, this “TechBio” pioneer uses automation, massive datasets and machine learning to identify new therapies faster than traditional labsdirectorstalkinterviews.comnasdaq.com. Its mission – “to decode biology to radically improve lives” – has attracted major industry partners and bold investors. But as an early-stage biotech with no approved drugs, Recursion’s stock can be a rollercoaster ride, swayed by scientific milestones and market sentiment alike. In early October 2025, Recursion’s stock made headlines after a sudden surge
8 October 2025
···
AiRWA (YYAI) Stock Soars 44% on $100M Crypto Pivot – Expert Insights

AiRWA (YYAI) Stock Soars 44% on $100M Crypto Pivot – Expert Insights

Company Background and Pivot AiRWA Inc (formerly Connexa Sports) built its name in sports technology. Its flagship was the Slinger Bag – a portable, AI-enhanced tennis ball machine – and it acquired analytics firms like Gameface AI and PlaySight to create a “Watch–Play–Learn” sports-tech ecosystemts2.tech. Under CEO Mike Ballardie, Connexa integrated AI vision systems and smart sensors to provide real-time coaching feedback (e.g. stroke analysis) to athletests2.tech. In Sept 2021 the company paid $24M to acquire Gameface AI, touting sports-AI market growth of ~28.7% per yearts2.tech. These moves signaled a strategy to become a connected sports-technology player. However, in mid-2025
8 October 2025
··
Webull’s Wild Ride: Inside BULL Stock’s 500% Surge, 85% Crash & What’s Next for the Trading App Giant

Webull’s Wild Ride: Inside BULL Stock’s 500% Surge, 85% Crash & What’s Next for the Trading App Giant

Company Overview Webull is a digital investment platform that offers commission-free trading of stocks, ETFs, options, cryptocurrencies and more via a popular mobile app and web interfacecmcmarkets.com. Often likened to Robinhood, Webull makes money primarily through payment for order flow and premium add-on servicescmcmarkets.com. The platform launched in 2018 and quickly gained traction among tech-savvy retail investors with its sleek design and zero-commission model. Webull now serves customers in North America, Europe, Asia, Africa, and beyond, operating in 14 markets through its licensed broker-dealer entitiesstockanalysis.com. Originally founded in 2016 as part of a Chinese fintech venture, Webull was backed early by Chinese
8 October 2025
·
Quantum Gold Rush: Inside D-Wave (QBTS) Stock’s 2600% Surge – Hype or Game-Changer?

Quantum Gold Rush: Inside D-Wave (QBTS) Stock’s 2600% Surge – Hype or Game-Changer?

Above sources in brackets. The surge in D-Wave Quantum’s stock price has captivated markets, but is it a quantum leap forward for investors or a bubble waiting to burst? The in-depth report below examines what’s driving the rally, the company’s progress and challenges, and whether this “quantum gold rush” can last. A 2025 Tech Stock Phenomenon: D-Wave’s Astronomic Rise Few stocks have soared like D-Wave Quantum (NYSE: QBTS) in 2025. After languishing as a penny stock in late 2024, D-Wave’s share price went parabolic this year – gaining nearly +300% year-to-date and over +3,000% since last October ts2.tech. On October
8 October 2025
···
QuantumScape’s EV Battery Breakthrough Sends Stock Soaring – Will the High-Voltage Hype Last?

QuantumScape’s EV Battery Breakthrough Sends Stock Soaring – Will the High-Voltage Hype Last?

QuantumScape’s High-Voltage Rally Explained QuantumScape’s stock went into “blast-off mode” in late September and early October 2025, buoyed by major developments in its technology and partnerships. After trading flat around $12–$13 through mid-September, QS suddenly broke out on successive news catalysts: it jumped 18% on Sept 18, then another +18.4% on Oct 1, ultimately hitting an intraday high of $16.49 by Oct 3 ts2.tech. The Oct 3 close at $15.92 capped a stunning ~30% gain in one week and a ~172% year-to-date rise ts2.tech. This rally far outpaced broader markets and made QuantumScape one of 2025’s top-performing tech stocks. Trading
8 October 2025
··
Joby Aviation’s $500 Million Stock Gamble Triggers Selloff – Can the Air Taxi Dream Still Soar?

Joby Aviation’s $500 Million Stock Gamble Triggers Selloff – Can the Air Taxi Dream Still Soar?

Joby’s $500M Stock Offering and Selloff Joby Aviation – a California-based developer of all-electric vertical takeoff and landing (eVTOL) air taxis – shocked investors on Oct. 7, 2025 by announcing a major stock sale after a year of surging share prices. The company launched a $500 million underwritten public offering of common stock, selling 30.5 million shares at $16.85 each (with an option for underwriters to buy 4.575 million more) ir.jobyaviation.com. Morgan Stanley is the sole book-runner on the deal ir.jobyaviation.com. The offering will gross approximately $513.9 million (or up to ~$589M if the extra shares are sold) ir.jobyaviation.com, bolstering Joby’s balance sheet for the
8 October 2025
1 … 1,136 1,137 1,138 1,139 1,140 … 1,171

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop